CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. Legal access does not necessarily equate to financial access. million people.

Access 89

Access Patients Pharmaceutical Education 89

MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. Note that chronic pain refers to the persistent or long-lasting discomfort in the body beyond the normal time frame for healing. The ways chronic pain manifests varies and includes musculoskeletal pain affecting the muscles, bones, ligaments, tendons, and joints.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MGC Pharma

FEBRUARY 22, 2018

An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain. Unfortunately, the regulatory process is fraught with bottlenecks, with no more than 500 Australians having legal access to Medical Cannabis. namely Australia’s aging population.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

NORML

FEBRUARY 1, 2019

Click here to email your lawmakers in support of banking access. Legislation is pending, House Bill 5442, to expand patients’ access to medical cannabis in Connecticut. The measure would expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronic pain.

Legislation 188

Legislation Decriminalization Access Patients 188

NORML

FEBRUARY 8, 2019

Legislation is pending, House Bill 5442, to expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronic pain. Click here to email your lawmakers in support of medical cannabis access in school. CT resident? FL resident? HI resident? IA resident?

Legislation 197

Legislation Decriminalization Patients Access 197

Canna Care Docs

DECEMBER 11, 2018

However, with medical cannabis continuing to spread through the country—and with more and more research pointing to its benefits for everything from chronic pain and sleep problems to anxiety and arthritis—the tide seems to be turning. Numerous studies point to that fact, especially in cases surrounding chronic pain and discomfort.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

JUNE 28, 2021

Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder. Kanabo is an established leader in medical cannabis research and innovation. Kanabo Group Plc. Michelle Tamir.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Veriheal

APRIL 21, 2022

It is a great day indeed especially for patients suffering from chronic pain—like medical cannabis advocate Pearl Schomburg—who can finally access this excellent alternative to other risky pharmaceutical treatments. .

Chronic Pain 97

Chronic Pain Pharmaceutical Medicine Patients 97

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. However, it is also being used for off-label infusions for the management of psychiatric disorders and chronic pain management (enter the clinics).

Therapy 104

Therapy Legalization Chronic Pain DEA 104

The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. These products are typically more accessible in larger cities.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Veriheal

AUGUST 13, 2020

THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronic pain. EPM-301 takes its name from the company EPM, a startup dedicated to bridging the gap between organic cannabis and the needs of pharmaceutical companies.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Remember, the pharmaceutical model is “this medicine addresses this specific target.” And both of these plant cannabinoids interact with TRP [ion] channels to help with inflammation and pain.

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

MedicalJane

OCTOBER 28, 2022

Millions of Americans, especially older individuals, are turning to medical marijuana for managing their chronic pain symptoms. This increasing number of states that have legalized medical marijuana makes it easier for patients to obtain a prescription from their doctor, making it more accessible than ever before.

Marijuana 86

Marijuana Chronic Pain Medicine Pharmaceutical 86

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

LifeCannMD

MARCH 3, 2025

Today, she maintains a discreet, effective regimen that has reduced her pharmaceutical intake by over half. The childproof containers can be challenging, but the medication itself is accessible.” Initially hesitant due to personal perceptions, Elena discovered marijuana THC edibles that transformed her treatment experience.

Edibles 52

Edibles Marijuana Dispensary Patients 52

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Therapy 40

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 75

Medicine Business Research and Development Chronic Pain 75

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 96

CBD Cannabinoids THC Extraction 96

MMJ Recs

JUNE 17, 2024

When dealing with chronic pain, finding relief can be a daily struggle for many people. Traditional pain medications often come with a slew of side effects and may not even provide adequate relief. Medicinal marijuana offers a natural and effective way to manage pain, with fewer adverse effects than traditional medications.

Strains 52

Strains Chronic Pain Indica Sativa 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JUNE 20, 2022

The FDA has also approved a few cannabis-based pharmaceutical drugs. Cannabis legalization is already showing that places with legal access to cannabis are seeing a drop in dependency on pharmaceutical prescriptions. Cannabis is helping patients fight cancer, control seizure disorders, fight chronic pain, and so much more.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

Cannabis Law Report

APRIL 22, 2019

Mr Plamandon said he successfully brought Thai-prescribed cannabis products into WA to treat his chronic pain on April 8. The rules don’t specify the country of origin of the prescription, but they do require travellers to have accessed the drug through a pharmacist.

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. But if that doctor has access to information from 40,000 patients it’s a different story.

Data 105

Data Clinical Trials Research and Development Indica 105

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

JANUARY 21, 2019

Britain tweaked legislation in November 2018 to allow specialist doctors in the UK to prescribe cannabis-based medicines to patients managing a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis.

Chronic Pain 72

Chronic Pain Medicine Education Patients 72

Veriheal

DECEMBER 10, 2021

This leaves the state’s medical patients with limited access to low-quality cannabis. Consumers of Delta-8 have said that the compound helps reduce pain, nausea, and anxiety while leaving the consumer with a clear head and stimulating appetite. Some even say Delta-8 is more effective than Delta-9 at treating chronic pain.

THC 98

THC Cannabinoids Hemp Chronic Pain 98

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Therapy Chronic Pain 40

Puff Puff Post

JUNE 5, 2019

As time started to pass by, the healing theories of marijuana plants were quickly replaced by those of big pharmaceutical companies. It wasn’t until the movement by thousands of patients and patient advocates in the 1990’s that propelled the government to allow fair access to medical marijuana. Legalization of recreational use.

Medicine 96

Medicine Patients Cannabinoids Oil 96

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. It also owns a majority stake in LVL Health , a chronic pain clinic, alongside a minority stake in cannabinoid-based biopharmaceutical company Kingdom Therapeutics.

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

Weedistry

DECEMBER 29, 2018

Most of the wave of incoming leaders after our recent midterm elections, at the state and federal level, support expanding access to medical marijuana. I previously worked as an emergency room doctor and have witnessed firsthand how helpful this drug can be for patients struggling with chronic pain and a myriad of symptoms.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45